Ajooni Biotech Limited (NSE:AJOONI)
4.520
+0.100 (2.26%)
Mar 10, 2026, 3:29 PM IST
Ajooni Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 33.72 | 21.61 | 11.25 | 10.49 | 3.73 | Upgrade
|
| Depreciation & Amortization | - | 10.94 | 8.74 | 10.05 | 9.7 | 4.37 | Upgrade
|
| Other Amortization | - | - | - | - | 1.41 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.02 | - | 0 | 0.11 | - | Upgrade
|
| Other Operating Activities | - | -4.71 | 3.48 | 3.84 | 7.95 | 7.05 | Upgrade
|
| Change in Accounts Receivable | - | -32.57 | 75.92 | -67.11 | -1.29 | -10.7 | Upgrade
|
| Change in Inventory | - | -86.2 | -7.37 | -11.12 | -5.06 | -20.91 | Upgrade
|
| Change in Accounts Payable | - | 19.11 | 85.27 | 33.12 | 13.99 | 34.68 | Upgrade
|
| Change in Other Net Operating Assets | - | -117.63 | 41.46 | -35.82 | -0.47 | -6.67 | Upgrade
|
| Operating Cash Flow | - | -177.37 | 229.1 | -55.79 | 36.84 | 11.56 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 218.74% | - | Upgrade
|
| Capital Expenditures | - | -20.32 | -56.02 | -13.6 | -21.24 | -35.27 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 9.56 | 0.34 | 0.04 | 0.99 | - | Upgrade
|
| Sale (Purchase) of Real Estate | - | - | - | -15 | - | - | Upgrade
|
| Investment in Securities | - | -169.46 | 127.03 | -131.73 | 1.27 | 1.17 | Upgrade
|
| Other Investing Activities | - | 8.88 | 5.01 | 2.05 | 0.01 | 0 | Upgrade
|
| Investing Cash Flow | - | -171.34 | 76.37 | -158.24 | -18.97 | -34.1 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 6.56 | - | 11.91 | Upgrade
|
| Long-Term Debt Issued | - | 2.58 | - | - | 6.79 | 5.67 | Upgrade
|
| Total Debt Issued | - | 2.58 | - | 6.56 | 6.79 | 17.58 | Upgrade
|
| Short-Term Debt Repaid | - | -4.86 | -29.45 | - | -21.12 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.65 | -8.3 | - | - | Upgrade
|
| Total Debt Repaid | - | -4.86 | -30.09 | -8.3 | -21.12 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -2.28 | -30.09 | -1.74 | -14.33 | 17.58 | Upgrade
|
| Issuance of Common Stock | - | 253.89 | - | 223.07 | - | 12 | Upgrade
|
| Other Financing Activities | - | -3.34 | -5.57 | -4.78 | -5.4 | -5.84 | Upgrade
|
| Financing Cash Flow | - | 248.26 | -35.66 | 216.55 | -19.73 | 23.74 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0 | - | 0 | - | Upgrade
|
| Net Cash Flow | - | -100.45 | 269.81 | 2.52 | -1.87 | 1.2 | Upgrade
|
| Free Cash Flow | - | -197.69 | 173.09 | -69.39 | 15.6 | -23.71 | Upgrade
|
| Free Cash Flow Margin | - | -17.06% | 21.57% | -9.32% | 2.11% | -4.65% | Upgrade
|
| Free Cash Flow Per Share | - | -1.15 | 1.98 | -1.16 | 0.31 | -0.47 | Upgrade
|
| Cash Interest Paid | - | 3.34 | 5.57 | 4.78 | 5.4 | 5.84 | Upgrade
|
| Cash Income Tax Paid | - | 8.75 | 5.42 | 4.48 | 1.57 | 0.1 | Upgrade
|
| Levered Free Cash Flow | - | -190.08 | -106.59 | -69.14 | 13 | -26.75 | Upgrade
|
| Unlevered Free Cash Flow | - | -190.08 | -106.59 | -69.14 | 13 | -26.75 | Upgrade
|
| Change in Working Capital | - | -217.29 | 195.27 | -80.93 | 7.18 | -3.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.